Do Antidepressant and Antianxiety Drugs Increase Chronicity in Affective Disorders?
The DOI matches its Crossref record.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been documented to occur after short-term use (1-month) of chlorpromazine in a patient with schizophrenia [164]”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [164]
In the citing paper
“Sequential treatment was thus able to favorably affect the long-term course of depressive illness and the longitudinal development of symptoms (rollback phenomenon).”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [21]
In the citing paper
“If prodromal symptoms may have a pathophysiological role in affective disorders and some residual symptoms may progress to become prodromal symptoms of relapse, then reduction or disappearance of residual symptomatology may entail a more favorable long-term outcome of depression.”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [21]
In the citing paper
“Yet it has been postulated that some cases of apparent tolerance may actually be due to long-term withdrawal or dependence which may, in turn, be affected by poor compliance to prescribed drugs for depression [2, 6].”
In the citing paper
“with the return of depressive symptoms of MDD occurring in 9-33% of patients across published trials [3].”
Citations
Cites
Still being checked.
Cited by
Treatment and prevention of depression
Hollon, S. D., Thase, M. E., & Markowitz, J. C. (2002) · Psychological Science in the Public Interest · doi:10.1111/1529-1006.00008 · Cited by 511
Prevention of Recurrent Depression With Cognitive Behavioral Therapy: Preliminary Findings
Fava, G. A., Rafanelli, C., Grandi, S., Conti, S., & Belluardo, P. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.9.816 · Cited by 491
Self-citationEfficacy and effectiveness of antidepressants: current status of research
Pigott, H. E., Leventhal, A. M., Alter, G. S., & Boren, J. J. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000318293 · Cited by 347
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Can long-term treatment with antidepressant drugs worsen the course of depression?
Fava, G. A. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0204 · Cited by 223
Self-citationThe mechanisms of tolerance in antidepressant action
Fava, G. A., & Offidani, E. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.026 · Cited by 158
“The neurobiologic mechanisms were not detailed in that paper (Fava, 1994), but were developed in a subsequent review that referred to the concept of oppositional tolerance (Fava, 2003).”
InfluentialSelf-citationContinuation and Maintenance Use of Antidepressants in Recurrent Depression
Bockting, C. L. H., ten Doesschate, M. C., Spijker, J., Spinhoven, P., Koeter, M. W. J., & Schene, A. H. (2008) · Psychotherapy and Psychosomatics · doi:10.1159/000110056 · Cited by 121
Long-Term Effects of Behavioural Treatment for Panic Disorder with Agoraphobia
Fava, G. A., Zielezny, M., Savron, G., & Grandi, S. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.166.1.87 · Cited by 116
Self-citationRaising Questions about Antidepressants
Antonuccio, D. O., Danton, W. G., DeNelsky, G. Y., Greenberg, R., & Gordon, J. S. (1999) · Psychotherapy and Psychosomatics · doi:10.1159/000012304 · Cited by 110
The Road to Recovery from Depression – Don’t Drive Today with Yesterday’s Map
Fava, G. A., Tomba, E., & Grandi, S. (2007) · Psychotherapy and Psychosomatics · doi:10.1159/000104701 · Cited by 110
Self-citationIncrease in Antidepressant Medication in the US Adult Population between 1990 and 2003
Mojtabai, R. (2008) · Psychotherapy and Psychosomatics · doi:10.1159/000112885 · Cited by 100
Natural History and Preventative Treatment of Recurrent Mood Disorders
Frank, P., & Thase, M. (1999) · Annual Review of Medicine · doi:10.1146/annurev.med.50.1.453 · Cited by 96
Recent developments in the pharmacotherapy of mood disorders.
Thase, M. E., & Kupfer, D. J. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.64.4.646 · Cited by 94
Depression Preceding Diagnosis of Bipolar Disorder
O’Donovan, C., & Alda, M. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00500 · Cited by 100
Fava, G. A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320970325 · Cited by 84
Self-citationPrevalence and Clinical Correlates of Residual Depressive Symptoms in Bipolar II Disorder
Benazzi, F. (2001) · Psychotherapy and Psychosomatics · doi:10.1159/000056260 · Cited by 83
Iatrogenic Factors in Psychopathology
Fava, G. A., & Rafanelli, C. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000500151 · Cited by 82
Self-citationFornaro, M., Anastasia, A., Novello, S., Fusco, A., Pariano, R., De Berardis, D., Solmi, M., Veronese, N., Stubbs, B., Vieta, E., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.10.025 · Cited by 80
Mixed Depression: Clinical Features and Predictors of Its Onset Associated with Antidepressant Use
Sani, G., Napoletano, F., Vöhringer, P. A., Sullivan, M., Simonetti, A., Koukopoulos, A., Danese, E., Girardi, P., & Ghaemi, N. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000358808 · Cited by 80
Tardive dysphoria: The role of long term antidepressant use in-inducing chronic depression
El‐Mallakh, R. S., Gao, Y., & Roberts, R. J. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.01.020 · Cited by 81
(2011) · Ethical Human Psychology and Psychiatry · doi:10.1891/1559-4343.13.2.169 · Cited by 313
Relapse and Recurrence of Depression: A Practical Approach for Prevention
Thase, M. E., & Sullivan, L. R. (1995) · CNS Drugs · doi:10.2165/00023210-199504040-00004 · Cited by 61
Fava, G. A. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.8.1109-a · Cited by 47
Self-citationWithdrawal Syndromes After Paroxetine and Sertraline Discontinuation
Fava, G. A., & Grandi, S. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199510000-00012 · Cited by 46
Self-citationTachyphylaxis in major depressive disorder: A review of the current state of research
Kinrys, G., Gold, A. K., Pisano, V. D., Freeman, M. P., Papakostas, G. I., Mischoulon, D., Nierenberg, A. A., & Fava, M. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.10.357 · Cited by 45
Roman, M. W. (2012) · Issues in Mental Health Nursing · doi:10.3109/01612840.2012.713447 · Cited by 36
STAR*D: A Tale and Trail of Bias
Pigott, H. E. (2011) · Ethical Human Psychology and Psychiatry · doi:10.1891/1559-4343.13.1.6 · Cited by 31
Potential Sensitising Effects of Antidepressant Drugs on Depression
Fava, G. A. (1999) · CNS Drugs · doi:10.2165/00023210-199912040-00001 · Cited by 23
Self-citationIncreased alcohol consumption in rats after subchronic antidepressant treatment
Alén, F., Orío, L., Gorriti, M. Á., de Heras, R. G., Ramírez-López, M. T., Pozo, M. A., & de Fonseca, F. R. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000217 · Cited by 24
Nelson, J. C., Rahman, Z. U., Laubmeier, K. K., Eudicone, J. M., McQuade, R. D., Berman, R., Marcus, R. N., Baker, R. A., & Sheehan, J. J. (2014) · CNS Spectrums · doi:10.1017/s109285291300103x · Cited by 20
Treating depression in clinical practice: new insights on the multidisciplinary use of trazodone
Albert, U., Tomasetti, C., Marra, C., Neviani, F., Pirani, A., Taddeo, D., Zanetti, O. O., & Maina, G. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1207621 · Cited by 20
Hammond, D. C. (2011) · Journal of Neurotherapy · doi:10.1080/10874208.2011.570694 · Cited by 23
Antidepressant-Induced Tardive Dysphoria
El-Mallakh, R. S., Gao, Y., Briscoe, B. T., & Roberts, R. J. (2011) · Psychotherapy and Psychosomatics · doi:10.1159/000316799 · Cited by 13
Xiao, C., Zhou, J. L., Li, A., Zhang, L., Zhu, X., Zhou, J., Hu, Y., Zheng, Y., Liu, J., Deng, Q., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.28817 · Cited by 14
Relabeling the Medications We Call Antidepressants
Antonuccio, D. O., & Healy, D. T. (2012) · Scientifica · doi:10.6064/2012/965908 · Cited by 16
Screening and Diagnosis of Depression: Are Criteria Followed?
Fava, G. A. (1997) · Disease Management & Health Outcomes · doi:10.2165/00115677-199702010-00001 · Cited by 11
Self-citationFarmaci antidepressivi nella pratica psichiatrica : efficacia reale
Migone, P. (2005) · doi:10.1400/64882 · Cited by 10
Residual symptoms in depression.
Iglesias, C., & Alonso, M. (2009) · Actas Españolas de Psiquiatría · Cited by 14
Number of episodes and antidepressant response in major depression
Joffe, R. T., Young, L. T., LEVITT, A. J., MacQUEEN, G. M., MARRIOTT, M. J., & Robb, J. C. (1999) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145799001443 · Cited by 11
Watchful waiting for depression using depathologization, advice and shared decision making
Kostic, M. V., Milojevic, T., Buzejić, J., Stojaković, M. S., Maslak, J., Ilić, M., Jakovljevic, A., Munjiza, A., Podgorac, A., Dabetic, M., et al. (2024) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2024.100753 · Cited by 14
Antidepressant discontinuation in treatment resistant depression
Ali, Z. A., Nuss, S., & El‐Mallakh, R. S. (2019) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2019.100383 · Cited by 8
Tardive dysphoria: antidepressant-induced chronic depression
El‐Mallakh, R. S., Roberts, R. J., Swann, A. C., Rutherford, P. R., & Surja, A. (2011) · Irish Journal of Psychological Medicine · doi:10.1017/s0790966700011976 · Cited by 6
Obtaining Informed Consent When a Profession Labels Itself as Providing Treatment for Mental Illness
Littrell, J. L. (2003) · Social Work in Mental Health · doi:10.1300/j200v01n04_07 · Cited by 6
Young, L. T., Cooke, R. G., Levitt, A. J., & Joffe, R. T. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00230-e · Cited by 6
The use of antidepressant drugs: some reasons for concern
Fava, G. A., & Tomba, E. (1998) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-1998-155 · Cited by 5
Self-citationDe (in)effectiviteit van psychofarmaca
van den Burg, W. (1998) · Directieve therapie · doi:10.1007/bf03060189 · Cited by 5
Whitaker, R. B. (2007) · Journal of College Student Psychotherapy · doi:10.1300/j035v21n03_05 · Cited by 5
An Editor’s Journey Ends, but the Journal’s Mission Continues
Fava, G. A. (2022) · Psychotherapy and Psychosomatics · doi:10.1159/000524654 · Cited by 5
Self-citationAn Integrative Approach to Depression: Part 2—Assessment and Treatment
Zuess, J. G. (2003) · Complementary health practice review · doi:10.1177/1076167502250784 · Cited by 5
Diamond, D. B. (1997) · Psychiatry · doi:10.1080/00332747.1997.11024788 · Cited by 3
The Clinical Meaning of Withdrawal with Antidepressant Drugs
Fava, G. A. (2024) · Psychotherapy and Psychosomatics · doi:10.1159/000540033 · Cited by 4
Self-citationRandomized Controlled Trials and the Efficacy of Psychotropic Medications
Dunlop, B. W., & Ribeiro, C. M. D. F. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_4 · Cited by 3
Prescription for Critical Thinking: A Discussion of Psychotropic Medication and Counseling
Biggs, B. W. (2015) · JMU Scholoraly Commons (James Madison University) · Cited by 2
Fava, G. A. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000511544 · Cited by 2
Self-citationKönnen Antidepressiva den langfristigen Verlauf depressiver Erkrankungen negativ verändern?
Gründer, G., Mertens, L. J., Spangemacher, M., & Schmitz, C. N. (2025) · Der Nervenarzt · doi:10.1007/s00115-025-01801-1 · Cited by 1
Diagnosis as a Detriment: A Cognitive Approach to Understanding the Depressive Experience
Einstein, E. H. (2015) · Ethical Human Psychology and Psychiatry · doi:10.1891/1559-4343.17.2.125 · Cited by 1
Randomized Controlled Trials and the Efficacy of Psychotropic Medications
Dunlop, B. W., & Ribeiro, C. M. D. F. (2019) · Springer eBooks · doi:10.1007/978-3-319-56015-1_4-1 · Cited by 2
Schneider, C., & Wissink, T. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35868-2.00005-0 · Cited by 2
Schneider, C., & Lovett, E. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1793-8.00004-2 · Cited by 1
STONE, C. K., & Garver, D. L. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.8.1109
BRUCE, T. J. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.8.1109-b
Depresión Crónica y Refractaria
Howland, R. H. (1996) · RET: revista de toxicomanías
Jansson, L., & Nordgaard, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-33249-9_7
The End Product: Clinical Practice Guidelines
Whitaker, R., & Cosgrove, L. (2015) · Palgrave Macmillan US eBooks · doi:10.1057/9781137516022_8
L'étudiant en philosophie et la poursuite d'une stratégie de renforcement du bien-être
Fava, G. A. (2018) · Elsevier eBooks · doi:10.1016/b978-2-294-76050-1.00002-7
Self-citationKostic, M. V., Vuković, O., Munjiza, A., Pešić, D., Vezmar, M., Podgorac, A., Ranđelović, D., Mandić-Maravić, V., Todorović, D., Jakovljević, A., et al. (2020) · Psihijatrija danas · doi:10.5937/psihdan2001025k
Schneider, C., & Lovett, E. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-2954-0.50013-2
Fava, G. A. (2018) · Elsevier eBooks · doi:10.1016/b978-2-294-76050-1.00001-5
Self-citationFava, G. A. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.8.aj15381109
Self-citationMeisenzahl, E. M., & Wege, N. (2022) · Elsevier eBooks · doi:10.1016/b978-3-437-23031-8.00010-8
Gründer, G. (2024) · Elsevier eBooks · doi:10.1016/b978-3-437-21199-7.00002-7
Gründer, G. (2024) · Elsevier eBooks · doi:10.1016/b978-3-437-21199-7.00001-5
Schneider, C., & Lovett, E. (2009) · Elsevier eBooks · doi:10.1016/b978-84-458-1911-1.50009-9
Metadata
- Authors
- Fava, G. A.
- Affiliations
- University of Bologna (IT)
- Corresponding author
- Fava, Giovanni A.
- ORCID
- Fava, Giovanni A.
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2010-02-18
- Volume
- 61
- Issue
- 3-4
- Pages
- 125-131
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2008115074
- Cited by
- 73
- References
- 0
- Citations by year
- 2025: 1 · 2024: 4 · 2023: 2 · 2022: 3 · 2020: 5 · 2019: 3 · 2018: 4 · 2017: 1 · 2016: 1 · 2015: 3 · 2014: 2 · 2013: 1 · 2012: 3
- FWCI
- 2.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- antidepressants, antianxiety drugs, chronicity, mood disorders, depression, anxiety disorders, relapse
- MeSH terms
- Antidepressive Agents, Chronic Disease, Humans, Risk Factors, Anti-Anxiety Agents, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.